Last reviewed · How we verify
gentamycin and clindamycin
At a glance
| Generic name | gentamycin and clindamycin |
|---|---|
| Sponsor | Shahid Beheshti University of Medical Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Dual vs. Single-Antibiotic Impregnated Cement in Hemiarthroplasty for Femoral Neck Fracture (PHASE3)
- Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial (PHASE4)
- Clindamycin Once a Day in Septic Abortion (PHASE4)
- Refobacin Revision-3 Bone Cement Post-Market Study
- TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden (PHASE3)
- Treatment of Chorioamnionitis After Delivery (NA)
- Pharmacokinetic Study of Vancomycin, Clindamycin And/or Gentamicin Administration During Surgery Using a Microdialysis Procedure (PHASE1)
- Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- gentamycin and clindamycin CI brief — competitive landscape report
- gentamycin and clindamycin updates RSS · CI watch RSS
- Shahid Beheshti University of Medical Sciences portfolio CI